Email this article Biomimetic proopiomelanocortin suppresses capsaicin-induced sensory irritation in humans
Abstract
Sensitive skin is a frequently mentioned cosmetic complaint. Addition of a biomimetic of neuromediator has recently appeared as a promising new way to cure skin care product problems. This study was aimed to assess the inhibitory effect of a biomimetic lipopeptide derived from proopiomelanocortin (bPOMC) on capsaicin-induced sensory irritation in human volunteers and also to compare its protective effect with that of the well-known anti irritant strontium chloride. The effect of each test compound was studied on 28 selected healthy volunteers with sensitive skin in accordance with a double-blind vehicle-controlled protocol. From day 1 to day 13 each group was applied the test compound (bPOMC or strontium chloride) to one wing of the nose and the corresponding placebo (vehicle) to the other side twice daily. On days 0 and 14, acute skin irritation was induced by capsaicin solution and quantified using clinical stinging test assessments. Following the application of capsaicin solution, sensory irritation was evaluated using a 4-point numeric scale. The sensations perceived before and after treatment (on days 0 and 14) was calculated for the two zones (test materials and vehicle). Ultimately the percentage of variation between each sample and the placebo and also the inhibitory effect of bPOMC compared to that of strontium chloride were reported. Clinical results showed that after two weeks treatment, the levels of skin comfort reported in the group treated with bPOMC were significantly higher than those obtained in the placebo group and the inhibitory effect of bPOMC was about 47% higher than that of strontium chloride. The results of the present study support the hypothesis that biomimetic peptides may be effective on sensitive skin.
Keywords
Full Text:
PDFReferences
Farage M, Katsarou A, Maibach H. Sensory, clinical and physiological factors in sensitive skin: a review. Contact Dermatitis. 2006;55(1):1-14.
Pons-Guiraud A. Sensitive skin: a complex and multifactorial syndrome. J Cosmet Dermatol. 2004;3(3):145-148.
Kligman A, Sadiq I, Zhen Y, Crosby M. Experimental studies on the nature of sensitive skin. Skin Res Technol. 2006;12(4):217-222.
Lupo M, Cole A. Cosmeceutical peptides. Dermatol Ther. 2007;20(5):343-349.
Zhang L, Falla TJ. Cosmeceuticals and peptides. Clin Dermatol. 2009;27(5):485-494.
Xie Y, Rizzi SC, Dawson R, Lynam E, Richards S, Leavesley DI, et al. Development of a three-dimensional human skin equivalent wound model for investigating novel wound healing therapies. Tissue Eng Part C Methods. 2010;16(5):1111-1123.
Fuller RW, Conradson TB, Dixon CM, Crossman DC, Barnes PJ. Sensory neuropeptide effects in human skin. Br J Pharmacol. 1987;92(4):781-788.
Lintner K, Mas-Chamberlin C, Mondon P, Peschard O, Lamy L. Cosmeceuticals and active ingredients. Clin Dermatol. 2009;27(5):461-468.
Slominski A, Wortsman J, Paus R, Elias PM, Tobin DJ, Feingold KR. Skin as an endocrine organ: implications for its function. Drug Discov Today Dis Mech. 2008;5(2):137-144.
Elias PM. Stratum corneum defensive functions: an integrated view. J Invest Dermatol. 2005;125(2):183-200.
Slominski A, Wortsman J. Neuroendocrinology of the skin. Endocr Rev. 2000;21(5):457-487.
Zouboulis CC. Human skin: an independent peripheral endocrine organ. Horm Res. 2000;54(5-6):230-242.
Raffin-Sanson ML, de Keyzer Y, Bertagna X. Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions. Eur J Endocrinol. 2003;149(2):79-90.
Luger TA, Scholzen T, Brzoska T, Becher E, Slominski A, Paus R. Cutaneous immunomodulation and coordination of skin stress responses by alpha-melanocyte-stimulating hormone. Ann N Y Acad Sci. 1998;840:381-394.
Arck PC, Slominski A, Theoharides TC, Peters EM, Paus R. Neuroimmunology of stress: skin takes center stage. J Invest Dermatol. 2006;126(8):1697-1704.
Roosterman D, Goerge T, Schneider SW, Bunnett NW, Steinhoff M. Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol Rev. 2006;86(4):1309-1379.
Slominski A. Neuroendocrine system of the skin. Dermatology. 2005;211(3):199–208.
Millington GW. Proopiomelanocortin (POMC): the cutaneous roles of its melanocortin products and receptors. Clin Exp Dermatol. 2006;31(3):407-412.
Slominski A, Wortsman J, Luger T, Paus R, Solomon S. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev. 2000;80(3):979–1020.
Bohm M, Luger TA. The role of melanocortins in skin homeostasis. Horm Res. 2000;54(5-6):287-293.
Altemus M, Rao B, Dhabhar FS, Ding W, Granstein RD. Stress-induced changes in skin barrier function in healthy women. J Invest Dermatol. 2001;117(2):309–317.
Slominski A, Wortsman J, Tuckey RC, Paus R. Differential expression of HPA axis homolog in the skin. Mol Cell Endocrinol. 2007;265-266:143-149.
Böhm M, Luger TA, et al. Cutaneous neuromodulation: the proopiomelanocortin system. Exp Clin Endocrinol Diabetes. 1999;107:225-228.
Luger TA. Neuromediators – a crucial component of the skin immune system. J Dermatol Sci. 2002;30(2):87–93.
Kondo S, Kono T, Sauder DN, McKenzie RC. IL-8 gene expression and production in human keratinocytes and their modulation by UVB. J Invest Dermatol. 1993;101(5):690-694.
Böhm M, Schulte U, Kalden H, Luger TA. Alpha-melanocyte-stimulating hormone modulates activation of NF-κB and AP-1 and secretion of interleukin-8 in human dermal fibroblasts. Ann N.Y Acad Sci. 2006;885:277-286.
Clausen BE, Girard-Madoux M. IL-10 control of dendritic cells in the skin. Oncoimmunology. 2013;2(3):e23186.
Laouini D, Alenius H, Bryce P, Oettgen H, Tsitsikov E, Geha R. IL-10 is critical for Th2 responses in a murine model of allergic dermatitis. J Clin Invest. 2003;112(7):1058-1066.
Nakagawa H, Hiura A. Capsaicin, transient receptor potential (TRP) protein subfamilies and the particular relationship between capsaicin receptors and small primary sensory neurons. Anat Sci Int. 2006;81(3):135-155.
Bode AM, Dong Z. The two faces of capsaicin. Cancer Res. 2011;71(8):2809-2814.
Schliemann S, Antonov D, Manegold N, Elsner P. The lactic acid stinging test predicts susceptibility to cumulative irritation caused by two lipophilic irritants. Contact Dermatitis. 2010;63(6):347-356.
Papoiu AD, Valdes-Rodriguez R, Nattkemper LA, Chan YH, Hahn GS, Yosipovitch G. A novel topical formulation containing strontium chloride significantly reduces the intensity and duration of cowhage-induced itch. Acta Derm Venereol. 2013;93(5):520-526.
Willis CM, Shaw S, De Lacharriere O, Baverel M, Reiche L, Jourdain R, et al. Sensitive skin: an epidemiological study. Br J Dermatol. 2001;145(2):258-263.
Diogo L, Papoila AL. Is it possible to characterize objectively sensitive skin? Skin Res Technol. 2010;16(1):30-37.
Dieamant Gde C, Velazquez Pereda Mdel C, Eberlin S, Nogueira C, Werka RM, Queiroz ML. Neuroimmunomodulatory compound for sensitive skin care: in vitro and clinical assessment. J Cosmet Dermat. 2008;7(2):112-119.
Primavera G, Berardesca E. Sensitive skin: mechanisms and diagnosis. Int J Cosmet Sci. 2005; 27(1):1–10.
Misery L, Myon E, Martin N, Consoli S, Boussetta S, Nocera T, et al. Sensitive skin: psychological effects and seasonal changes. J Eur Acad Dermatol Venereol. 2007;21(5):620–628.
Peters EM, Ericson ME, Hosoi J, Seiffert K, Hordinsky MK, Ansel JC, et al. Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance. J Invest Dermatol. 2006; 126(9):1937–1947.
Luger TA, Lotti T. Neuropeptides: Role in inflammatory skin diseases. J Eur Acad Dermatol Venereol. 1998;10(3):207–211.
Kono M, Nagata H, Umemura S, Kawana S, Osamura RY. In situ expression of corticotropin-releasing hormone (CRH) and proopiomelanocortin (POMC) genes in human skin. FASEB J. 2001;15(12):2297-2299.
Luger TA, Scholzen T, Grabbe S. The role of α-melanocyte-stimulating hormone in cutaneous biology. J Investig Dermatol Symp Proc. 1997;2(1):87-93.
Catania A, Gatti S, Colombo G, Lipton JM. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol Rev. 2004;56(1):1-29.
Hahn GS. Strontium is a potent and selective inhibitor of sensory irritation. Dermatol Surg. 1999;25(9):689-694.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.